Cervical Cancer
3 competing products in clinical development for Cervical Cancer.
Pipeline by Phase
Phase 23
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Sacituzumab tirumotecan plus Iparomlimab | Sun Pharmaceutical | Phase 2 | Recruiting | 42 |
| PRGN-2009 plus Pembrolizumab + Pembrolizumab alone | Precigen | Phase 2 | Recruiting | 36 |
| exatecan mesylate | Daiichi Sankyo | Phase 2 | Completed | 35 |